|
|
Ann R Coll Surg Engl. 1993 January; 75(1): 26–29. | PMCID: PMC2497734 |
Comparison of 'intraoperative' parathormone measurement with frozen section during parathyroid surgery. W. Madira, G. S. Robertson, N. J. London, S. J. Iqbal, P. R. Bell, and P. S. Veitch Department of Surgery, Leicester Royal Infirmary. Abstract Intact parathyroid hormone (PTHi) has a relatively short half-life and levels fall significantly within 15 min of the successful excision of all the abnormal parathyroid glands during surgery for hyperparathyroidism. Monitoring this fall has been suggested as useful in decreasing the failure rate of neck explorations in parathyroid surgery. We have performed a comparative study of the use, during surgery for primary hyperparathyroidism, of routine frozen section with the recently available rapid assay for PTHi. The assay demonstrated a significant fall (P = 0.013) in the level of PTHi from a pre-excision mean of 26.66 pmol/l to 5.94 pmol/l 15 min after surgical excision. In all cases the level of PTHi fell to less than 30% of pre-excision levels by 30 min. However, while frozen section results were available in a mean time of 22 min after excision, the PTHi levels took a mean of 105 min. We conclude that during straightforward parathyroid surgery for primary hyperparathyroidism, the current assay does not offer any advantages over the already routine use of frozen section. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (632K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - Mundy GR, Cove DH, Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet. 1980 Jun 21;1(8182):1317–1320. [PubMed]
- Heath H, 3rd, Hodgson SF, Kennedy MA. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med. 1980 Jan 24;302(4):189–193. [PubMed]
- Stevenson JC, Lynn JA. Time to end a conservative treatment for mild hyperparathyroidism. Br Med J (Clin Res Ed). 1988 Apr 9;296(6628):1016–1017. [PubMed]
- Auguste LJ, Attie JN, Schnaap D. Initial failure of surgical exploration in patients with primary hyperparathyroidism. Am J Surg. 1990 Oct;160(4):333–336. [PubMed]
- Gaz RD, Doubler PB, Wang CA. The management of 50 unusual hyperfunctioning parathyroid glands. Surgery. 1987 Dec;102(6):949–957. [PubMed]
- Cusumano RJ, Mahadevia P, Silver CE. Intraoperative histologic evaluation in exploration of the parathyroid glands. Surg Gynecol Obstet. 1989 Dec;169(6):506–510. [PubMed]
- Endres DB, Villanueva R, Sharp CF, Jr, Singer FR. Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: performance in the differential diagnosis of hypercalcemia and hypoparathyroidism. Clin Chem. 1991 Feb;37(2):162–168. [PubMed]
- Curley IR, Wheeler MH, Aston JP, Brown RC, Weeks I, Woodhead JS. Studies in patients with hyperparathyroidism using a new two-site immunochemiluminometric assay for circulating intact (1-84) parathyroid hormone. Surgery. 1987 Dec;102(6):926–931. [PubMed]
- Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, Keutmann HT, Wang CA, Potts JT, Jr, Segre GV. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 1987 Aug;33(8):1364–1367. [PubMed]
- Goltzman D, Gomolin H, DeLean A, Wexler M, Meakins JL. Discordant disappearance of bioactive and immunoreactive parathyroid hormone after parathyroidectomy. J Clin Endocrinol Metab. 1984 Jan;58(1):70–75. [PubMed]
- Nussbaum SR, Thompson AR, Hutcheson KA, Gaz RD, Wang CA. Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery. 1988 Dec;104(6):1121–1127. [PubMed]
- Flentje D, Schmidt-Gayk H, Fischer S, Stern J, Blind E, Buhr H, Herfarth C. Intact parathyroid hormone in primary hyperparathyroidism. Br J Surg. 1990 Feb;77(2):168–172. [PubMed]
- Davies C, Demeure MJ, St John A, Edis AJ. Study of intact (1-84) parathyroid hormone secretion in patients undergoing parathyroidectomy. World J Surg. 1990 May–Jun;14(3):355–360. [PubMed]
- Bergenfelz A, Nordén NE, Ahrén B. Intraoperative fall in plasma levels of intact parathyroid hormone after removal of one enlarged parathyroid gland in hyperparathyroid patients. Eur J Surg. 1991 Feb;157(2):109–112. [PubMed]
- O'Brien DP, Horgan PG, Gough DB, Skehill R, Grimes H, Given HF. CA15-3: a reliable indicator of metastatic bone disease in breast cancer patients. Ann R Coll Surg Engl. 1992 Jan;74(1):9–12. [PubMed]
- Lucas RJ, Welsh RJ, Glover JL. Unilateral neck exploration for primary hyperparathyroidism. Arch Surg. 1990 Aug;125(8):982–985. [PubMed]
- Udén P, Aspelin P, Berglund J, Lilja B, Nyman U, Olsson LE, Zederfeldt B. Preoperative localization in unilateral parathyroid surgery. A cost-benefit study on ultrasound, computed tomography and scintigraphy. Acta Chir Scand. 1990 Jan;156(1):29–35. [PubMed]
- Ryan MF, Jones SR, Barnes AD. Modification to a commercial immunoradiometric assay permitting intraoperative monitoring of parathyroid hormone levels. Ann Clin Biochem. 1990 Jan;27 (:65–68. [PubMed]
|
See letter "